Sign Up Today and Learn More About Terremoto Biosciences Stock
Invest in or calculate the value of your shares in Terremoto Biosciences or other pre-IPO companies through EquityZen's platform.
Terremoto Biosciences Stock (TERB)
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.
About Terremoto Biosciences Stock
Founded
2021
Headquarters
San Francisco, CA, US
Industries
Messaging and Telecommunications, Sports, Content and Publishing
Terremoto Biosciences Press Mentions
Stay in the know about the latest news on Terremoto Biosciences
Reversible lysine covalent modifiers of egfr and uses thereof
patents • Apr 02, 2025
Terremoto Biosciences patents AKT1 inhibitors for cancer
bioworld • Mar 01, 2025
Covalent modifiers of akt1 and uses thereof
patents • Feb 08, 2025
Covalent modifiers of akt1 and uses thereof
patents • Feb 08, 2025
Reversible lysine covalent modifiers of egfr and uses thereof
patents • Feb 08, 2025
Terremoto Biosciences Management
Leadership team at Terremoto Biosciences
Board Member
Kevin Koch
Board Member
Jeffrey Tong
Join now and verify your accreditation status to gain access to:
- Terremoto Biosciences Current Valuation
- Terremoto Biosciences Stock Price
- Terremoto Biosciences Management
- Available deals in Terremoto Biosciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Terremoto Biosciences Cap Table and Funding History by Share Class and Liquidity Preferences
- Terremoto Biosciences Revenue and Financials
- Terremoto Biosciences Highlights
- Terremoto Biosciences Business Model
- Terremoto Biosciences Risk Factors
- Terremoto Biosciences Research Report from SACRA Research
Trading Terremoto Biosciences Stock
How to invest in Terremoto Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Terremoto Biosciences through EquityZen funds. These investments are made available by existing Terremoto Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Terremoto Biosciences stock?
Shareholders can sell their Terremoto Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
